Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology
Neurodegenerative dementias are the most common group of neurodegenerative diseases affecting more than 40 million people worldwide. One of these diseases is frontotemporal dementia (FTD), an early onset dementia and one of the leading causes of dementia in people under the age of 60. FTD is a heter...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/18ebd0a1b7c642c4ba21658bca7a396c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:18ebd0a1b7c642c4ba21658bca7a396c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:18ebd0a1b7c642c4ba21658bca7a396c2021-11-10T06:12:54ZHuman Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology2296-634X10.3389/fcell.2021.766773https://doaj.org/article/18ebd0a1b7c642c4ba21658bca7a396c2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcell.2021.766773/fullhttps://doaj.org/toc/2296-634XNeurodegenerative dementias are the most common group of neurodegenerative diseases affecting more than 40 million people worldwide. One of these diseases is frontotemporal dementia (FTD), an early onset dementia and one of the leading causes of dementia in people under the age of 60. FTD is a heterogeneous group of neurodegenerative disorders with pathological accumulation of particular proteins in neurons and glial cells including the microtubule-associated protein tau, which is deposited in its hyperphosphorylated form in about half of all patients with FTD. As for other patients with dementia, there is currently no cure for patients with FTD and thus several lines of research focus on the characterization of underlying pathogenic mechanisms with the goal to identify therapeutic targets. In this review, we provide an overview of reported disease phenotypes in induced pluripotent stem cell (iPSC)-derived neurons and glial cells from patients with tau-associated FTD with the aim to highlight recent progress in this fast-moving field of iPSC disease modeling. We put a particular focus on genetic forms of the disease that are linked to mutations in the gene encoding tau and summarize mutation-associated changes in FTD patient cells related to tau splicing and tau phosphorylation, microtubule function and cell metabolism as well as calcium homeostasis and cellular stress. In addition, we discuss challenges and limitations but also opportunities using differentiated patient-derived iPSCs for disease modeling and biomedical research on neurodegenerative diseases including FTD.Rebekka KühnAayushi MahajanPeter CanollGunnar HargusGunnar HargusFrontiers Media S.A.articlefrontotemporal dementia (FTD)induced pluriopotent stem cellstaudisease modelingfrontotemporal lobar degeneration (FTLD)neurodegenenerative diseasesBiology (General)QH301-705.5ENFrontiers in Cell and Developmental Biology, Vol 9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
frontotemporal dementia (FTD) induced pluriopotent stem cells tau disease modeling frontotemporal lobar degeneration (FTLD) neurodegenenerative diseases Biology (General) QH301-705.5 |
spellingShingle |
frontotemporal dementia (FTD) induced pluriopotent stem cells tau disease modeling frontotemporal lobar degeneration (FTLD) neurodegenenerative diseases Biology (General) QH301-705.5 Rebekka Kühn Aayushi Mahajan Peter Canoll Gunnar Hargus Gunnar Hargus Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology |
description |
Neurodegenerative dementias are the most common group of neurodegenerative diseases affecting more than 40 million people worldwide. One of these diseases is frontotemporal dementia (FTD), an early onset dementia and one of the leading causes of dementia in people under the age of 60. FTD is a heterogeneous group of neurodegenerative disorders with pathological accumulation of particular proteins in neurons and glial cells including the microtubule-associated protein tau, which is deposited in its hyperphosphorylated form in about half of all patients with FTD. As for other patients with dementia, there is currently no cure for patients with FTD and thus several lines of research focus on the characterization of underlying pathogenic mechanisms with the goal to identify therapeutic targets. In this review, we provide an overview of reported disease phenotypes in induced pluripotent stem cell (iPSC)-derived neurons and glial cells from patients with tau-associated FTD with the aim to highlight recent progress in this fast-moving field of iPSC disease modeling. We put a particular focus on genetic forms of the disease that are linked to mutations in the gene encoding tau and summarize mutation-associated changes in FTD patient cells related to tau splicing and tau phosphorylation, microtubule function and cell metabolism as well as calcium homeostasis and cellular stress. In addition, we discuss challenges and limitations but also opportunities using differentiated patient-derived iPSCs for disease modeling and biomedical research on neurodegenerative diseases including FTD. |
format |
article |
author |
Rebekka Kühn Aayushi Mahajan Peter Canoll Gunnar Hargus Gunnar Hargus |
author_facet |
Rebekka Kühn Aayushi Mahajan Peter Canoll Gunnar Hargus Gunnar Hargus |
author_sort |
Rebekka Kühn |
title |
Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology |
title_short |
Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology |
title_full |
Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology |
title_fullStr |
Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology |
title_full_unstemmed |
Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology |
title_sort |
human induced pluripotent stem cell models of frontotemporal dementia with tau pathology |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/18ebd0a1b7c642c4ba21658bca7a396c |
work_keys_str_mv |
AT rebekkakuhn humaninducedpluripotentstemcellmodelsoffrontotemporaldementiawithtaupathology AT aayushimahajan humaninducedpluripotentstemcellmodelsoffrontotemporaldementiawithtaupathology AT petercanoll humaninducedpluripotentstemcellmodelsoffrontotemporaldementiawithtaupathology AT gunnarhargus humaninducedpluripotentstemcellmodelsoffrontotemporaldementiawithtaupathology AT gunnarhargus humaninducedpluripotentstemcellmodelsoffrontotemporaldementiawithtaupathology |
_version_ |
1718440445910974464 |